Upcoming Webinar Infection Prevention | Covid_19 Virus 2020 | Infection Control Webinar Conferences

Theme: Infection Control and Measures during Covid-19 Pandemic

Infection Prevention 2020

Renowned Speakers

Peter P Karpawich
Wayne State University
USA

Marisa Egan
Saint Josephâ€™s University
USA

Christy Cotner
California Baptist University
USA

James C. Pace
Associate Dean New York University
USA

Leena Bhattacharya Mithal
Northwestern University
USA

John P Breinholt
University of Texas McGovern Medical School
USA

Sunny Po
University of Oklahoma Health Sciences Center
USA

Francis J Castellino
University of Notre Dame
USA

Kartikeya Makker
University of Florida College of Medicine Jacksonville
USA

Laura Finn
Mayo Clinic
USA

Zharov Vladimir P
University of Arkansas for Medical Sciences
USA

William J Rowe
Medical University of Ohio
USA

K C Santosh
University of South Dakota
USA

Joshua K.
Underwood Vermont Academy
USA

Salwa Ahmed Elgebaly
Nour Heart Institute
USA

Glenn S Tillotson
Cempra Pharmaceuticals
USA

Jason A Thompson
Emergency Products & Research, Inc.,
USA

Shantanu Bhatt
Saint Josephâ€™s University
USA

M Khalid Ijaz
City University of New York
USA

Issam A Mikati
Northwestern University
USA

Guillermo R. Valdes
Miami Dade College BenjamÃn LeÃ³n School of Nursing
USA

Ricardo DurÃ£es Carvalho
Massachusetts Institute of Technology
USA

Durgesh Sinha
Temple University
USA

Anil Kaul
Oklahoma State University
USA

Benfang Lei
Montana State University
USA

Zelenkova Hana
DOST SvidnÃk
Slovenia

Sara M Dann
University of Texas Medical Branch
USA

Elizabeth De Nardo
GOJO Industries Inc
USA

Saungi McCalla
White Plains Hospital
USA

Lia Monica Junie
University of Medicine and Pharmacy
Romania

Christine I Wooddell
Arrowhead Pharmaceuticals
USA

Paul Kadetz
Drew University
USA

Hafid Soualhine
National Public Health Institute of Quebec
Canada

Shirley Gutkowsi
Primal Air LLC
USA

Harpal S. Mangat
Howard College of Medicine
USA

Hua Zhu
Rutgers New Jersey Medical School
USA

Roland Ndip Ndip
University of Buea
USA

Nichola Ashby
University of Nottingham
UK

Joanna Zajkowska
Medical University of Bialystok
Poland

Joon-Seok Chae
Seoul National University
North Korea

Hilary Whyte
Medical Director University of Toronto
Canada

Ruoling Chen
Wellbeing University of Wolverhampton
UK

Jean-Pierre Usdin
American Hospital of Paris
France

Cathy M Holt
University of Manchester
UK

Sandro Innaconeoi
San Raffaele hospital
Italy

Ascension Marcos
Spanish National Research Council
Spain

Patrick Timpel
Technische Universitaet Dresden
Germany

Fekry ElDeeb
Zulekha Hospitals
United Arab Emirates

Shireen Samargandy
King Abdulaziz University
Saudi Arabia

Sarah Al-Gahtani
Al-Maarefa University of Science and Technology
Saudi Arabia

Infection Prevention 2020

Infection Prevention Webinar welcomes all the Pathologists and Infectious Specialists throughout the world to attend Infection Prevention 2020 Webinar which will be held during September 16-17, 2020.

Theme: Infection Control and Measures during Covid-19 Pandemic

â€‹Infection Prevention Webinar 2020 creates a platform where we gather outstanding internationally known Pathologists, Infection Prevention Online Conference and world-class researchers, presenters, exhibitors from premier medical universities, hospitals, companies, research centers, clinics etc., to speak on annual advancements, breakthroughs and developments in Infection Prevention Online Webinar, Pathology Webinar Conferences and Infectious Diseases through several sessions on keynotes, symposia, case-studies, lectures and much more.

The webinar format will feature new interactive workshop sessions for Infection Prevention and Pathology topics which will discuss new updates and management, as well as State of the Art talks on a variety of Infectious diseases in multiple subspecialties.

Infection Prevention 2020 Virtual Meeting hosts new 'Awards Nomination and Presentation' features to Speakers in appreciation to their research works towards the Global Neonatology and Perinatology advancements which include - Scientific Service Achievement Award, Research Contribution Award, Upcoming Researcher Award, Women of Science Award, Outstanding speaker, Best Keynote Speaker, Best Poster Presentation, Young Researcher Award (YRF) and so on; from Expert level to Student Level.

The themes of the webinar will include the following topics:

Infection Prevention and Control, Covid_19 Infections, Causes and symptoms of infections, SARS Coronavirus, Infection Control Procedures, Global Trends in Emerging Infections, Global Market on Infections, Infection Control in Critical Care, Emerging and Re-Emerging Infections, Epidemiology of Emerging and Re-Emerging Infections, Immunizations

Infection Prevention 2020 conference brings together an International collaboration of Scientists, Researchers, Infectious Diseases Specialists from leading universities and research institutions, company sponsors making the conference a perfect platform to share experience, foster collaboration across industry and academia, and evaluate emerging technologies across the globe.

Target Audience

Infectious Diseases Experts
Pathologists
Infectious Diseases Specialists
Pharmacists
Epidemiologists
Health Care Professionals
Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Infection Prevention and Infection Control Specialists
Infection Prevention Organizations & Companies
Immunologists

Why to Attend??

Infection Prevention 2020 is giving a worldwide stage to analysts that afford new insights into the concealed methods of Infection Control and Prevention. World-eminent speakers, guest of honours, and the most up to date upgrades are particular components of this gathering and with individuals from around the globe concentrated on finding out about uncommon illnesses and its advances; An expanding number of distinguished methods makes it important to complete propelled research here of irresistible sicknesses. Infection Prevention 2020 conference is your best chance to achieve the biggest collection of members, conduct presentations, disseminate data, B2B meetings, meet with potential scientists, trade learning on late improvements and make an unmistakable imprint by invigorating development at this event.

Young Research’s Awards at Infection Prevention 2020

Infection Prevention 2020 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Infection Prevention and Control.

Young Research’s Awards at Infection Prevention 2020 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Infection Prevention-2020.

YRF Registration Benefits:

Young Scientist Award recongination certificate and memento to the winners
Infection Prevention-2020 provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Infection Prevention-2020.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till May 30 – $399
Till June 28 – $499
Till July 26 – $599

Track 1: Infection Prevention and Control

Infection care and management (IPC) may be a scientific approach and sensible answer designed to control the effect caused by infection to patients and medical examiners. One among the foremost necessary routes for transmission of infection is that the hands. Hands that infected with any contaminated item, surface or object may be contaminated with germs from that supply. The contagious transmit might deals with raw food, animals, and spattered nappies, dirty surfaces like bathrooms or hands contaminated/ infected with nasal secretion or spit when reflex, coughing or drooling. Infection hindrance associate degree management. It aims to safeguard those that could be liable to getting an infection, each within the general community and whereas receiving care thanks to health issues. Health care analysis is exposure to blood, saliva, several body fluids or aerosols which will transmit infectious materials like viral hepatitis, HIV, or different blood borne or humour microorganism. It prevents contact with probably infectious diseases by making a physical barrier between the potential infectious materials.

7^th Infectious Diseases Conferences, February 24-25, 2020 Berlin, Germany; 5th World Congress on Public Health and Nutrition on February 24-25, 2020 London, UK; 15th world Conference on Infectious Diseases, Prevention and Control March 19-20, 2020 Dubai, UAE; International Conference on infectious disease November 25-26, 2020, Tokyo, Japan; 5th International Conference on Infectious Diseases: Control and Prevention on October 05-06, 2020 Amsterdam, Netherlands; International Conference on Infectious Diseases, Microbiology and Beneficial Microbes on May 13-14,2020 Zagreb, Croatia.

Relative Societies:

Europe:

Infection Prevention Society, Healthcare Infection Society, British Society of Parasitology, Surgical Infection Society, European Society of Clinical Microbiology and Infectious Diseases, European Association of Infection Control.

USA:

Texas Society of Infection Prevention and Control, American Society of Microbiology, Canadian Society for Immunology, International AIDS Society, Infectious Diseases Society of America, National Association of Infection Prevention and Control , American Society of Infection Prevention.

Asia Pacific:

Pediatric Infectious Disease Society of Thailand, Infection Control Association, The Japanese Association for Infectious Diseases, Australasian Society for Infectious Diseases, Chinese Society for Immunology, Asia Pacific Society of Infection Control, Korean Association of Infection Disease Prevention, Korea.

Track 2: Covid_19 Infections:

The most number of affected pregnant women is increasing, but scarce information is available about the clinical features Obstetrics Infections outcomes of pregnant patients with COVID-19 in pregnancy caused by severe acute respiratory syndrome coronavirus Moreover maternal, fetal, and neonatal outcomes of patients who were infected in late pregnancy appeared very good, and these outcomes were achieved with intensive, active management that might be the best practice in the absence of more robust data. The clinical characteristics of these patients with COVID-19 during pregnancy were similar to those of non-pregnant adults with COVID-19 clinical symptoms from 33 Infections with or at risk of COVID-19 were mild and outcomes were favourable of the 3 neonates with symptomatic COVID-19, presented with early-onset SARS-CoV-2 infection. Because strict infection control and prevention procedures were implemented during the delivery, it is likely that the sources of SARS-CoV-2 in the clinical findings or investigations suggestive of COVID-19 affected to mothers, and all samples, including amniotic fluid, cord blood, and breast milk, were negative for SARS-CoV-2. The vertical maternal-fetal transmission cannot be ruled out in the current cohort. Therefore, it is crucial to screen pregnant women and implement strict infection control measures, quarantine of infected mothers, and close monitoring of at risk of COVID-19.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 3: Causes and Symptoms of Infections

Infections can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 4: SARS Coronavirus

Coronavirus disease (COVID-19) is an infectious disease caused by a new virus that had not been previously identified in humans. The virus causes respiratory illness (like the flu) with symptoms such as a cough, fever and in more severe cases, pneumonia. The new coronavirus spreads primarily through contact with an infected person when they cough or sneeze, or through droplets of saliva or discharge from the nose. More rarely, the disease can be fatal. Older people, and people with other medical conditions (such as asthma, diabetes, or heart disease), may be more vulnerable to becoming severely ill. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic; they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. In the past two weeks, the number of cases of COVID-19 outside China has increased 13-fold, and the number of affected countries has tripled. There are now more than 118,000 cases in 114 countries and 4,291 people have lost their lives. Thousands more are fighting for their lives in hospitals. In the days and weeks ahead, we expect to see the number of cases, the number of deaths, and the numbers of affected countries climb even higher.

Symptoms & Precautions:

Common signs of infection include respiratory symptoms, fever, and cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 5: Infection Control Procedures

Infection control deals with procedures and activities which bring to prevent or reduce the risk of transmission of infectious diseases. It is mainly works in a clinical setting or working in certain laboratories are at risk of occupational exposure to blood borne pathogens including hepatitis B (Hep B), hepatitis C (Hep C) and human immune deficiency virus (HIV) as well as occupational exposure to a range of microbiological agents. Standard analysis is the work practices needed to achieve a major level of infection control and prevention. The use of common precautions aims to reduce, and to eliminate the adequate risk of transmission of infection, particularly those caused by blood borne viruses. Microorganisms are present on hands (resident flora) or acquired during healthcare activities (transient flora). In Particular hand hygiene is to reduce the number of microorganisms on your hands, particularly transient flora which may present the greater risk for infection transmission.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 6: Global Trends in Emerging Infections

An infection whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 7: Global Market on Infections

Global market report of infections is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 8: Infection Control in Critical Care

Caution is very important within the medical care unit (ICU). "We generally see a lot of infections in this population due to the length of time they may be in a unit. Infections acquired in the hospitals, especially in the intensive care unit (ICU) settings, ranging between 15% and 20%, may further lead to complications in >40% in critically ill patients. The order of incidence may vary in different settings, but the most usual causes are ventilator-associated pneumonia, intravascular catheter-associated bloodstream infection, catheter-associated urinary tract infection, posttraumatic intra-abdominal infection, and surgical site infection. Designated infection control teams should supervise the process and help in collection and compilation of data. Antibiotic Stewardship Recommendations include constituting a team, close coordination between teams, audit, formulary restriction, de-escalation, optimizing dosing, active use of information technology among other measure.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 9: Emerging and Re-Emerging Infections

When disease is caused by an organism that is newly identified and not known previously to infect humans or has changed in susceptibility to an anti-infectious drug, it is commonly called an emerging infectious disease, or simply an emerging infection. The RNA viruses that cause seasonal human epidemics of influenza are highly unstable genetically and mutate frequently during replication. Mutation, or genetic drift, results in susceptibility of individuals regardless of their exposure to the viruses before drift, requiring annual antigenic modifications in seasonal influenza vaccines to ensure protection. The short incubation period, and the mild illness caused by the majority of infections, especially among school aged children, result in rapid transmission potential that leads to seasonal influenza epidemics.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 10: Epidemiology of Emerging and Re-Emerging Infections

Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 11: Immunizations:

Immunization is that the strategy whereby a methodology is involved in immune or proof against a disease, typically by the administration of AN immunogenic. It is one among cost-effective health investments, with verified strategies that build it accessible to even the foremost hard-to-reach and vulnerable populations. Immunizations are often stated as less risky and an appropriate way to become immune to a particular disease than risking a milder form of the disease itself. Other molecules are used for protection further, for example in experimental vaccines against nicotine (NicVAX) or the hormone ghrelin in experiments to create an obesity vaccine. They are necessary for every adult and youngsters therein they will shield themselves from the numerous diseases out there. Immunization not solely protects kids against deadly diseases but jointly helps in developing children's immune systems.

Relative Societies:

Europe:

USA:

Asia Pacific:

Infection Prevention 2020 is nonpareil and open platform to explore and gain the knowledge in the field of Life science. This conference brings together professors, researchers, scientists, students in all the areas of medical sciences, pharmaceutical, Life sciences, Medical associations and societies, enables an international forum to explore the approved research. Conference Series is delighted to invite you all to attend and register for the “16^th World Congress on Infection Prevention and Control” scheduled for September 16-17, 2020 at Dubai, UAE.

The organizing committee is gearing up for an exciting and informative conference program this year also which includes plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the where you will be sure to have a meaningful experience with scholars from around the world. All members of the Infection Prevention 2020 organizing committee look forward to meeting you in Dubai, UAE.

Infectious Diseases:

Infections are caused by microorganisms resides inside the host body. The colonization of microbes is beneficial and sometimes fatal, vary according to the host immune resistance and drug susceptibility. In general biologist classified living organisms which are called as bacteria, virus, protozoa, fungi, Parasites, Prions, Viroid’s (plant pathogens, they affect the health of plants). The overlap of the kingdoms in this figure is intentional, because, given the evolution of increasingly complex and diverse species.

Human with infection causing agent inside the body called host and organisms as parasite. These tiny microbes colonize inside the body and reproduce. The organism that causes infection is also called as infectious agent. The resided organism that harms a host's health is often called a pathogen. The infection can be varied to different stages in accordance to various types of infectious agents that establishes successful site of infection in the host cause disease. Infectious agents come in many shapes and sizes. The single celled microscopic organisms are called Bacteria and protozoa, while viruses are even smaller. Fungi grow like plants and helminths that resemble worms.

The Middle East and Africa Infectious Disease Therapeutics Market accounts for USD 8.42 Billion in 2018 and assessed to achieve 12.29 USD Billion by the end of 2023 with a developing potential of 7.877 %. The Middle East and Africa Infectious disease therapeutics market are categorized based on Mode of treatment into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on the target organism the market is categorized into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is categorized into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the Middle East and Africa Infectious disease therapeutics market is analysed under various regions namely the Middle East and Africa. The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period.

The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.

The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.

Related Companies/Industries:

Abbott Diagnostics
Alere Acquisition Update
Thermo Fisher Scientific Inc.
Alere Reader
Beckman Coulter, Inc. / Danaher
Becton, Dickinson and Company (BD)
BD Max Molecular
ID/AST
POC Veritor
bioMrieux Inc.
Astellas Pharma
Bayer
AstraZeneca
Chimerix Pharmaceuticals
GlaxoSmithKline
Novartis
AMGEN

Related Associations and Societies:

International Union of Microbiological Societies
European Society of Clinical Microbiology and Infectious Diseases
Federation of Infection Societies
Canadian Society of Microbiologists
British Infection Association
Federation of European Microbiological Societies
Welsh Microbiology Association
Clinical Virology Network
American Society for Microbiology
Society for General Microbiology
Infectious Diseases Society of America
International Society for Infectious Diseases
Clinical Infectious Diseases Society
National Institute of Allergy and Infectious Disease
Pediatric Infectious Diseases Society
Institute for global health and infectious diseases
International Union Against Tuberculosis and Lung Disease, Paris, France
Australasian Society for Infectious Diseases
Society of Infectious Diseases Pharmacists
European Society for Paediatric Infectious Diseases

Funds Allotment towards Infectious Diseases Research:

Burroughs Welcome Fund (CAMS) for Medical Students - Up to $700,000
Doris Duke Clinical Research International Fellowship for Medical Students-Up to $28,000
American Association of University Women-International Fellowships- Up to $30,000
American Cancer Society- Up to $45,000 annually
American College of Physicians International Fellowship Exchange Program- Up to $7,000
Christine Mirzayan Science and Technology Policy Graduate Fellowship Program-$8,000
Elizabeth Glaser Pediatric AIDS Foundation Two-Year International Scholars Award-Up to $30,000

Why Dubai?

Dubai is a city and emirate in the United Arab Emirates known for luxury shopping, ultramodern architecture and a lively nightlife scene. Burj Khalifa Dubai is known for luxury shopping, modern architecture, and a lively nightlife scene. Burj Khalifa, with its 830m the tallest building in the world, dominates the skyscraper-filled skyline

Dubai is UAE’s most important key features for health care for fastest growing economic sectors worldwide. The city is cluster of related companies and associations that includes 280 Medical Technology companies, 260 biotech and Pharmaceutical companies, with 130 clinics and 20+ large Research centres specializing in Health care and life sciences.

Most visited tourist Spots in Dubai, UAE:

Burj Khalifa
Palm Jumeirah
Burj Al Arab
Dubai Aquarium & Underwater Zoo
Dubai Mall
Miracle Garden Dubai

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 16-17, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View